Hhn, J., Ehrlich, S., Fleischer, B
7 PCCA members with clinical services access may contact our Clinical Services team for help with microdosing GLP-1 RAs and other compounding concerns
In our future work, we will examine the comparative effectiveness of alternative treatment options for obesity in patients who discontinue semaglutide or tirzepatide, to help patients and their clinicians make informed decisions. Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education
Kevin discusses osteopenia and osteoporosis, emphasizing the importance of understanding bone density and turnover markers
1 2 Journal of Neuroscience Research
TennCares recent commitment to expanding coverage for obesity medications isnt just a policy update: it is a lifeline for thousands of Tennesseans and a rare opportunity for our state to lead the nation in treating one of its most urgent health crises